F, C., & H, W. (2019). Chemoimmunotherapy for stage IV non-small-cell lung cancer - Authors' reply. The Lancet. Oncology, 20(9), e467. https://doi.org/10.1016/S1470-2045(19)30544-3
Chicago Style (17th ed.) CitationF, Cappuzzo, and West H. "Chemoimmunotherapy for Stage IV Non-small-cell Lung Cancer - Authors' Reply." The Lancet. Oncology 20, no. 9 (2019): e467. https://doi.org/10.1016/S1470-2045(19)30544-3.
MLA (9th ed.) CitationF, Cappuzzo, and West H. "Chemoimmunotherapy for Stage IV Non-small-cell Lung Cancer - Authors' Reply." The Lancet. Oncology, vol. 20, no. 9, 2019, p. e467, https://doi.org/10.1016/S1470-2045(19)30544-3.
Warning: These citations may not always be 100% accurate.